data_6f27_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6f27 _Structure_validation_residue.Date_analyzed 2018-01-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -86.91 121.54 71.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.677 0.275 . . . . 1.0 110.413 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 23.4 Cg_endo -62.58 133.45 42.65 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.993 2.462 . . . . 1.0 112.141 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 15.9 Cg_exo -66.89 128.34 18.63 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.972 2.448 . . . . 1.0 112.508 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.66 1.18 37.06 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.698 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -112.7 151.56 30.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.528 -0.175 . . . . 1.0 110.528 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.863 -178.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 ptm180 -75.73 136.09 70.91 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.137 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 14.7 Cg_exo -70.25 148.0 60.91 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.601 2.201 . . . . 1.0 111.695 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.53 114.63 2.07 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.816 2.344 . . . . 1.0 112.296 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.97 76.58 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.912 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 53.7 m-85 -105.35 147.29 28.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.157 0.504 . . . . 1.0 110.807 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.744 -179.544 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -89.07 117.04 67.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 121.065 -0.254 . . . . 1.0 110.328 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.898 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 12.8 Cg_exo -70.76 138.13 33.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.743 2.296 . . . . 1.0 111.34 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -58.15 117.98 4.78 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.174 2.583 . . . . 1.0 112.904 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.18 -2.78 54.8 Favored Glycine 0 C--O 1.234 0.154 0 CA-C-N 115.925 -0.579 . . . . 1.0 112.985 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.898 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 64.4 m-85 -111.05 140.93 45.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.076 0.465 . . . . 1.0 111.402 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.335 -178.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.998 -0.371 . . . . 1.0 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -83.06 145.08 48.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.732 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.45 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 36.6 Cg_endo -66.48 131.48 26.42 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.71 2.274 . . . . 1.0 112.411 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.9 138.18 61.68 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.047 2.498 . . . . 1.0 112.846 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.07 -20.59 49.93 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.534 -0.757 . . . . 1.0 112.9 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 59.1 m-85 -91.56 111.83 23.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.2 0.524 . . . . 1.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.779 -179.356 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -82.74 121.5 77.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.398 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 Cg_endo -65.84 138.94 55.17 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.742 2.295 . . . . 1.0 112.558 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 22.2 Cg_exo -65.54 153.33 78.68 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.526 2.151 . . . . 1.0 112.301 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.73 -2.0 55.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.955 -0.64 . . . . 1.0 112.051 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -114.69 135.27 54.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.551 0.215 . . . . 1.0 110.656 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.126 178.459 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.755 0.312 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -89.88 133.8 33.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.54 156.35 52.84 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.85 2.367 . . . . 1.0 112.162 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 140.42 57.39 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.494 2.13 . . . . 1.0 111.964 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.26 -8.96 41.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.744 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -116.48 111.73 20.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.794 -0.446 . . . . 1.0 109.794 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.93 -178.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 36.0 mmt180 -90.21 136.98 28.05 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.6 0.238 . . . . 1.0 110.601 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 21.6 Cg_exo -67.08 129.5 20.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.692 2.261 . . . . 1.0 112.232 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 143.09 88.88 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.632 2.222 . . . . 1.0 111.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.05 -13.31 45.0 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.817 -0.706 . . . . 1.0 111.512 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -112.6 111.03 21.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.113 -178.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.476 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 60.2 mtt180 -74.22 123.95 89.59 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 17.4 Cg_exo -67.66 155.5 69.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.979 2.452 . . . . 1.0 112.135 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.55 141.28 91.01 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.411 2.074 . . . . 1.0 112.495 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.08 43.26 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.629 -0.714 . . . . 1.0 112.42 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -90.46 118.6 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.964 0.411 . . . . 1.0 110.72 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.983 -179.048 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.872 0.368 . . . . 1.0 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.31 139.3 36.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.981 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.844 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 6.1 Cg_exo -76.32 129.58 11.29 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.539 2.16 . . . . 1.0 111.516 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.12 121.65 10.04 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.009 2.472 . . . . 1.0 113.342 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.19 -11.99 48.28 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 1.0 113.036 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.844 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -105.87 126.31 52.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.068 0.461 . . . . 1.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.645 -179.355 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.1 pttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.936 0.398 . . . . 1.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 64.3 mtt180 -92.58 136.28 25.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.105 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.704 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 10.8 Cg_exo -71.53 129.49 15.82 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.845 2.363 . . . . 1.0 111.676 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.06 118.81 5.71 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.86 2.373 . . . . 1.0 112.956 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.91 9.62 86.52 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.928 -0.654 . . . . 1.0 113.729 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.704 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 61.6 m-85 -115.9 136.65 52.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.919 0.36 . . . . 1.0 111.022 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.045 -179.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.8 tttm . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.482 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -73.03 126.61 90.34 Favored Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.868 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 3.0 Cg_exo -75.11 143.89 29.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.901 2.4 . . . . 1.0 111.918 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.4 124.29 15.79 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.806 2.338 . . . . 1.0 112.661 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.82 79.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.594 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.868 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 61.9 m-85 -107.97 121.98 45.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.394 0.616 . . . . 1.0 110.757 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.011 -178.579 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.63 122.64 87.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 6' ' ' PHE . 38.0 Cg_endo -67.74 154.7 72.52 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.024 2.482 . . . . 1.0 113.037 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.79 144.89 92.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.257 2.638 . . . . 1.0 112.195 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.05 45.4 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.954 -0.566 . . . . 1.0 112.098 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 3' ' ' PRO . 62.9 m-85 -103.21 119.02 38.09 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.848 -178.096 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.671 0.272 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.77 141.13 28.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.235 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 21.4 Cg_exo -65.64 136.14 44.81 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.846 2.364 . . . . 1.0 112.288 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.67 123.97 14.97 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.119 2.546 . . . . 1.0 112.271 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.04 -12.2 68.64 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.181 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.669 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 60.5 m-85 -114.06 111.79 22.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.089 0.471 . . . . 1.0 110.152 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.917 179.228 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.537 0.208 . . . . 1.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.8 mtp85 -91.43 143.46 28.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.694 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 27.8 Cg_exo -63.11 130.6 29.41 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.678 2.252 . . . . 1.0 112.085 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 16.7 Cg_exo -67.95 111.32 2.39 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.748 2.298 . . . . 1.0 112.925 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.88 -10.08 34.53 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 121.147 -0.549 . . . . 1.0 113.545 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.42 153.43 26.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.864 0.332 . . . . 1.0 111.266 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 1.0 109.801 178.011 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.871 0.367 . . . . 1.0 110.727 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -76.9 149.81 80.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.626 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 34.4 Cg_endo -63.31 129.37 25.23 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.771 2.314 . . . . 1.0 112.49 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.34 144.68 86.62 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.569 2.18 . . . . 1.0 111.204 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.73 -8.59 79.01 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.756 -0.735 . . . . 1.0 111.529 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.626 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -118.7 153.19 34.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.737 -0.211 . . . . 1.0 110.58 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.748 0.308 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 57.7 ttp180 -88.5 122.56 69.38 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.393 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 7.7 Cg_exo -72.1 128.81 14.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.656 2.237 . . . . 1.0 111.701 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.56 126.29 16.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.984 2.456 . . . . 1.0 112.779 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.39 -11.73 65.13 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.923 -0.656 . . . . 1.0 112.6 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.669 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 65.4 m-85 -109.33 110.78 22.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.042 0.448 . . . . 1.0 110.988 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.834 179.048 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.535 0.207 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 84.1 mtt180 -86.45 140.11 33.95 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.599 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 22.5 Cg_exo -66.49 146.13 78.97 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 1.0 111.877 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 142.87 99.8 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.451 2.101 . . . . 1.0 111.899 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.38 -9.12 41.68 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.632 -0.587 . . . . 1.0 111.632 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.65 111.48 23.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.921 0.391 . . . . 1.0 110.26 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.977 179.329 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.16 -0.311 . . . . 1.0 110.16 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -81.13 138.61 49.07 Favored Pre-proline 0 N--CA 1.448 -0.539 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.6 146.64 94.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.02 2.48 . . . . 1.0 112.271 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.42 148.0 82.64 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.044 2.496 . . . . 1.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.23 40.87 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.959 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.6 111.99 24.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.746 -177.723 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.961 0.41 . . . . 1.0 111.008 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -83.01 156.61 67.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.304 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.693 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 30.7 Cg_exo -61.69 130.14 30.35 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.7 2.267 . . . . 1.0 112.206 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 8.0 Cg_exo -71.23 113.94 3.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 123.5 2.8 . . . . 1.0 112.996 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.18 -11.27 58.43 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.054 -0.521 . . . . 1.0 113.598 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.693 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 62.7 m-85 -92.16 117.5 29.92 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.031 -0.532 . . . . 1.0 111.22 -178.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.912 0.387 . . . . 1.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -77.3 146.48 74.4 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.262 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 129.21 19.66 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 1.0 112.143 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.21 154.28 46.47 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.239 2.626 . . . . 1.0 112.488 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.36 -7.8 40.42 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.645 -0.788 . . . . 1.0 113.311 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -92.16 126.43 37.24 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.629 -0.336 . . . . 1.0 110.983 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.358 179.019 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -86.91 121.54 71.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.677 0.275 . . . . 1.0 110.413 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 23.4 Cg_endo -62.58 133.45 42.65 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.993 2.462 . . . . 1.0 112.141 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 15.9 Cg_exo -66.89 128.34 18.63 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.972 2.448 . . . . 1.0 112.508 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.66 1.18 37.06 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.698 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -112.7 151.56 30.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.528 -0.175 . . . . 1.0 110.528 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 m -57.43 131.18 81.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.863 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.49 121.34 3.37 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.936 2.424 . . . . 1.0 111.17 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.149 177.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 ptm180 -75.73 136.09 70.91 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.137 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 14.7 Cg_exo -70.25 148.0 60.91 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.601 2.201 . . . . 1.0 111.695 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.53 114.63 2.07 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.816 2.344 . . . . 1.0 112.296 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.97 76.58 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.912 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 53.7 m-85 -105.35 147.29 28.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.157 0.504 . . . . 1.0 110.807 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m -122.58 148.78 53.99 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.744 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -80.58 121.08 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.68 2.254 . . . . 1.0 110.037 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 C--N 1.305 -1.356 0 CA-C-N 115.217 -0.901 . . . . 1.0 110.224 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -89.07 117.04 67.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 121.065 -0.254 . . . . 1.0 110.328 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.898 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 12.8 Cg_exo -70.76 138.13 33.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.743 2.296 . . . . 1.0 111.34 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -58.15 117.98 4.78 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.174 2.583 . . . . 1.0 112.904 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.18 -2.78 54.8 Favored Glycine 0 C--O 1.234 0.154 0 CA-C-N 115.925 -0.579 . . . . 1.0 112.985 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.898 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 64.4 m-85 -111.05 140.93 45.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.076 0.465 . . . . 1.0 111.402 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.2 m -80.46 149.97 69.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.335 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 3.0 Cg_endo -82.52 120.7 3.23 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.087 2.525 . . . . 1.0 111.129 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.608 178.736 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.998 -0.371 . . . . 1.0 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -83.06 145.08 48.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.732 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.45 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 36.6 Cg_endo -66.48 131.48 26.42 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.71 2.274 . . . . 1.0 112.411 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.9 138.18 61.68 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.047 2.498 . . . . 1.0 112.846 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.07 -20.59 49.93 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.534 -0.757 . . . . 1.0 112.9 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 59.1 m-85 -91.56 111.83 23.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.2 0.524 . . . . 1.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m -114.36 149.55 42.31 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.779 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -81.36 120.01 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.688 2.259 . . . . 1.0 110.031 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 . . . . . 0 C--N 1.312 -1.054 0 CA-C-N 115.375 -0.83 . . . . 1.0 110.625 -179.077 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -82.74 121.5 77.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.398 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 Cg_endo -65.84 138.94 55.17 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.742 2.295 . . . . 1.0 112.558 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 22.2 Cg_exo -65.54 153.33 78.68 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.526 2.151 . . . . 1.0 112.301 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.73 -2.0 55.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.955 -0.64 . . . . 1.0 112.051 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -114.69 135.27 54.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.551 0.215 . . . . 1.0 110.656 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 m -57.86 156.46 18.76 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.126 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.82 118.6 4.85 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.295 1.997 . . . . 1.0 111.724 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 C--N 1.309 -1.163 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.36 177.069 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.755 0.312 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -89.88 133.8 33.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.54 156.35 52.84 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.85 2.367 . . . . 1.0 112.162 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 140.42 57.39 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.494 2.13 . . . . 1.0 111.964 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.26 -8.96 41.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.744 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -116.48 111.73 20.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.794 -0.446 . . . . 1.0 109.794 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.8 m -62.43 127.86 90.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.93 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.8 Cg_endo -82.79 120.22 3.05 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.333 2.689 . . . . 1.0 111.509 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.646 178.24 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 36.0 mmt180 -90.21 136.98 28.05 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.6 0.238 . . . . 1.0 110.601 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 21.6 Cg_exo -67.08 129.5 20.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.692 2.261 . . . . 1.0 112.232 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 143.09 88.88 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.632 2.222 . . . . 1.0 111.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.05 -13.31 45.0 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.817 -0.706 . . . . 1.0 111.512 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -112.6 111.03 21.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m -122.21 138.57 29.17 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.113 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.1 Cg_endo -82.4 121.32 3.4 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.845 2.363 . . . . 1.0 111.105 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 115.186 -0.915 . . . . 1.0 110.01 178.055 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.476 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 60.2 mtt180 -74.22 123.95 89.59 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 17.4 Cg_exo -67.66 155.5 69.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.979 2.452 . . . . 1.0 112.135 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.55 141.28 91.01 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.411 2.074 . . . . 1.0 112.495 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.08 43.26 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.629 -0.714 . . . . 1.0 112.42 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -90.46 118.6 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.964 0.411 . . . . 1.0 110.72 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m -85.79 129.9 52.77 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.983 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.7 Cg_endo -82.29 120.78 3.34 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.678 2.252 . . . . 1.0 110.097 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.397 -0.811 . . . . 1.0 110.508 -179.147 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.872 0.368 . . . . 1.0 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.736 ' HD3' ' HG3' ' A' ' 8' ' ' PRO . 88.7 mtt180 -85.31 139.3 36.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.981 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.844 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 6.1 Cg_exo -76.32 129.58 11.29 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.539 2.16 . . . . 1.0 111.516 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.12 121.65 10.04 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.009 2.472 . . . . 1.0 113.342 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.19 -11.99 48.28 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 1.0 113.036 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.844 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -105.87 126.31 52.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.068 0.461 . . . . 1.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.4 m -83.94 127.03 68.79 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.645 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.736 ' HG3' ' HD3' ' A' ' 2' ' ' ARG . 53.2 Cg_endo -84.97 120.69 2.31 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 122.812 2.341 . . . . 1.0 111.695 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.465 -0.778 . . . . 1.0 110.27 177.564 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.1 pttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.936 0.398 . . . . 1.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 64.3 mtt180 -92.58 136.28 25.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.105 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.704 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 10.8 Cg_exo -71.53 129.49 15.82 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.845 2.363 . . . . 1.0 111.676 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.06 118.81 5.71 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.86 2.373 . . . . 1.0 112.956 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.91 9.62 86.52 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.928 -0.654 . . . . 1.0 113.729 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.704 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 61.6 m-85 -115.9 136.65 52.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.919 0.36 . . . . 1.0 111.022 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 m -93.75 139.9 22.88 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.045 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.3 Cg_endo -82.28 121.16 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.166 2.577 . . . . 1.0 110.788 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.206 -0.906 . . . . 1.0 110.536 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.8 tttm . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.482 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -73.03 126.61 90.34 Favored Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.868 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 3.0 Cg_exo -75.11 143.89 29.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.901 2.4 . . . . 1.0 111.918 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.4 124.29 15.79 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.806 2.338 . . . . 1.0 112.661 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.82 79.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.594 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.868 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 61.9 m-85 -107.97 121.98 45.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.394 0.616 . . . . 1.0 110.757 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.3 m -122.09 149.69 54.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.011 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.0 OUTLIER -81.89 122.15 3.8 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.061 2.507 . . . . 1.0 110.444 177.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.004 179.322 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.63 122.64 87.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 6' ' ' PHE . 38.0 Cg_endo -67.74 154.7 72.52 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.024 2.482 . . . . 1.0 113.037 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.79 144.89 92.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.257 2.638 . . . . 1.0 112.195 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.05 45.4 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.954 -0.566 . . . . 1.0 112.098 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 3' ' ' PRO . 62.9 m-85 -103.21 119.02 38.09 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.0 m -64.97 121.15 72.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.848 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 3.0 Cg_endo -83.44 122.2 3.14 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 123.5 2.8 . . . . 1.0 109.92 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--N 1.31 -1.134 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.427 -179.487 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.671 0.272 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.77 141.13 28.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.235 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 21.4 Cg_exo -65.64 136.14 44.81 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.846 2.364 . . . . 1.0 112.288 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.67 123.97 14.97 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.119 2.546 . . . . 1.0 112.271 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.04 -12.2 68.64 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.181 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.669 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 60.5 m-85 -114.06 111.79 22.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.089 0.471 . . . . 1.0 110.152 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m -120.88 153.99 57.46 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.917 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -80.35 119.54 3.82 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.232 1.955 . . . . 1.0 110.601 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 C--O 1.253 1.26 0 CA-C-N 114.812 -1.086 . . . . 1.0 110.884 179.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.537 0.208 . . . . 1.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.8 mtp85 -91.43 143.46 28.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.694 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 27.8 Cg_exo -63.11 130.6 29.41 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.678 2.252 . . . . 1.0 112.085 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 16.7 Cg_exo -67.95 111.32 2.39 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.748 2.298 . . . . 1.0 112.925 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.88 -10.08 34.53 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 121.147 -0.549 . . . . 1.0 113.545 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.42 153.43 26.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.864 0.332 . . . . 1.0 111.266 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.4 m -86.96 136.11 34.5 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 1.0 109.801 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -80.66 119.95 3.8 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 C-N-CA 122.265 1.977 . . . . 1.0 110.488 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 C--N 1.305 -1.343 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.649 179.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.871 0.367 . . . . 1.0 110.727 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -76.9 149.81 80.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.626 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 34.4 Cg_endo -63.31 129.37 25.23 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.771 2.314 . . . . 1.0 112.49 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.34 144.68 86.62 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.569 2.18 . . . . 1.0 111.204 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.73 -8.59 79.01 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.756 -0.735 . . . . 1.0 111.529 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.626 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -118.7 153.19 34.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 m -118.72 131.27 24.37 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.737 -0.211 . . . . 1.0 110.58 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.92 121.74 3.7 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.728 2.285 . . . . 1.0 110.375 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.897 -179.523 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.748 0.308 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 57.7 ttp180 -88.5 122.56 69.38 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.393 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 7.7 Cg_exo -72.1 128.81 14.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.656 2.237 . . . . 1.0 111.701 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.56 126.29 16.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.984 2.456 . . . . 1.0 112.779 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.39 -11.73 65.13 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.923 -0.656 . . . . 1.0 112.6 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.669 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 65.4 m-85 -109.33 110.78 22.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.042 0.448 . . . . 1.0 110.988 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -87.13 152.62 53.31 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.834 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.59 121.0 3.26 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 C-N-CA 122.116 1.877 . . . . 1.0 110.386 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--N 1.309 -1.176 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.909 179.815 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.535 0.207 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 84.1 mtt180 -86.45 140.11 33.95 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.599 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 22.5 Cg_exo -66.49 146.13 78.97 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 1.0 111.877 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 142.87 99.8 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.451 2.101 . . . . 1.0 111.899 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.38 -9.12 41.68 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.632 -0.587 . . . . 1.0 111.632 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.65 111.48 23.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.921 0.391 . . . . 1.0 110.26 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.2 m -78.0 119.56 77.86 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.977 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.49 119.94 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.841 2.36 . . . . 1.0 111.523 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.163 -1.381 . . . . 1.0 111.443 178.793 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.16 -0.311 . . . . 1.0 110.16 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -81.13 138.61 49.07 Favored Pre-proline 0 N--CA 1.448 -0.539 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.6 146.64 94.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.02 2.48 . . . . 1.0 112.271 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.42 148.0 82.64 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.044 2.496 . . . . 1.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.23 40.87 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.959 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.6 111.99 24.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.473 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.6 m -78.82 123.38 85.26 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.746 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.77 121.94 3.81 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.788 2.326 . . . . 1.0 109.787 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.247 0.946 0 O-C-N 124.434 1.084 . . . . 1.0 110.413 -179.353 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.961 0.41 . . . . 1.0 111.008 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -83.01 156.61 67.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.304 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.693 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 30.7 Cg_exo -61.69 130.14 30.35 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.7 2.267 . . . . 1.0 112.206 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 8.0 Cg_exo -71.23 113.94 3.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 123.5 2.8 . . . . 1.0 112.996 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.18 -11.27 58.43 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.054 -0.521 . . . . 1.0 113.598 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.693 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 62.7 m-85 -92.16 117.5 29.92 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.8 m -98.13 108.41 46.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.031 -0.532 . . . . 1.0 111.22 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 2.6 Cg_endo -83.43 120.95 2.92 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 123.197 2.598 . . . . 1.0 111.044 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.254 1.316 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.653 178.214 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.912 0.387 . . . . 1.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -77.3 146.48 74.4 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.262 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 129.21 19.66 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 1.0 112.143 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.21 154.28 46.47 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.239 2.626 . . . . 1.0 112.488 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.36 -7.8 40.42 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.645 -0.788 . . . . 1.0 113.311 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -92.16 126.43 37.24 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.629 -0.336 . . . . 1.0 110.983 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 16.9 m -97.11 136.72 21.37 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.358 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.9 Cg_endo -83.06 119.86 2.89 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.45 2.1 . . . . 1.0 111.655 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 C--O 1.249 1.073 0 O-C-N 124.252 0.97 . . . . 1.0 112.209 177.757 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -86.91 121.54 71.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.677 0.275 . . . . 1.0 110.413 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 23.4 Cg_endo -62.58 133.45 42.65 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.993 2.462 . . . . 1.0 112.141 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 15.9 Cg_exo -66.89 128.34 18.63 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.972 2.448 . . . . 1.0 112.508 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.66 1.18 37.06 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.698 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -112.7 151.56 30.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.528 -0.175 . . . . 1.0 110.528 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.863 -178.077 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 ptm180 -75.73 136.09 70.91 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.137 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 14.7 Cg_exo -70.25 148.0 60.91 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.601 2.201 . . . . 1.0 111.695 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.53 114.63 2.07 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.816 2.344 . . . . 1.0 112.296 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.97 76.58 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.912 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 53.7 m-85 -105.35 147.29 28.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.157 0.504 . . . . 1.0 110.807 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.744 -179.544 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -89.07 117.04 67.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 121.065 -0.254 . . . . 1.0 110.328 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.909 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 12.8 Cg_exo -70.76 138.13 33.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.743 2.296 . . . . 1.0 111.34 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -58.15 117.98 4.78 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.174 2.583 . . . . 1.0 112.904 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.18 -2.78 54.8 Favored Glycine 0 C--O 1.234 0.154 0 CA-C-N 115.925 -0.579 . . . . 1.0 112.985 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.909 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 64.4 m-85 -111.05 140.93 45.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.076 0.465 . . . . 1.0 111.402 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.335 -178.874 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.998 -0.371 . . . . 1.0 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -83.06 145.08 48.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.732 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 36.6 Cg_endo -66.48 131.48 26.42 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.71 2.274 . . . . 1.0 112.411 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.9 138.18 61.68 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.047 2.498 . . . . 1.0 112.846 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.07 -20.59 49.93 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.534 -0.757 . . . . 1.0 112.9 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 59.1 m-85 -91.56 111.83 23.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.2 0.524 . . . . 1.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.779 -179.356 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -82.74 121.5 77.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.398 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 Cg_endo -65.84 138.94 55.17 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.742 2.295 . . . . 1.0 112.558 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 22.2 Cg_exo -65.54 153.33 78.68 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.526 2.151 . . . . 1.0 112.301 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.73 -2.0 55.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.955 -0.64 . . . . 1.0 112.051 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -114.69 135.27 54.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.551 0.215 . . . . 1.0 110.656 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.126 178.459 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.755 0.312 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -89.88 133.8 33.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.54 156.35 52.84 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.85 2.367 . . . . 1.0 112.162 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 140.42 57.39 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.494 2.13 . . . . 1.0 111.964 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.26 -8.96 41.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.744 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -116.48 111.73 20.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.794 -0.446 . . . . 1.0 109.794 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.93 -178.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 2' ' ' ARG . 36.0 mmt180 -90.21 136.98 28.05 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.6 0.238 . . . . 1.0 110.601 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 21.6 Cg_exo -67.08 129.5 20.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.692 2.261 . . . . 1.0 112.232 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 143.09 88.88 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.632 2.222 . . . . 1.0 111.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.05 -13.31 45.0 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.817 -0.706 . . . . 1.0 111.512 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -112.6 111.03 21.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.113 -178.618 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 60.2 mtt180 -74.22 123.95 89.59 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 17.4 Cg_exo -67.66 155.5 69.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.979 2.452 . . . . 1.0 112.135 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.55 141.28 91.01 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.411 2.074 . . . . 1.0 112.495 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.08 43.26 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.629 -0.714 . . . . 1.0 112.42 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -90.46 118.6 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.964 0.411 . . . . 1.0 110.72 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.983 -179.048 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.872 0.368 . . . . 1.0 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 88.7 mtt180 -85.31 139.3 36.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.981 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.85 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 6.1 Cg_exo -76.32 129.58 11.29 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.539 2.16 . . . . 1.0 111.516 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 52.5 Cg_exo -54.12 121.65 10.04 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.009 2.472 . . . . 1.0 113.342 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.19 -11.99 48.28 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 1.0 113.036 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.85 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -105.87 126.31 52.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.068 0.461 . . . . 1.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.645 -179.355 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.1 pttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.936 0.398 . . . . 1.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 64.3 mtt180 -92.58 136.28 25.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.105 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.711 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 10.8 Cg_exo -71.53 129.49 15.82 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.845 2.363 . . . . 1.0 111.676 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 28.0 Cg_exo -61.06 118.81 5.71 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.86 2.373 . . . . 1.0 112.956 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.91 9.62 86.52 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.928 -0.654 . . . . 1.0 113.729 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.711 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 61.6 m-85 -115.9 136.65 52.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.919 0.36 . . . . 1.0 111.022 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.045 -179.106 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.8 tttm . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -73.03 126.61 90.34 Favored Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.881 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 3.0 Cg_exo -75.11 143.89 29.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.901 2.4 . . . . 1.0 111.918 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 47.0 Cg_exo -57.4 124.29 15.79 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.806 2.338 . . . . 1.0 112.661 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.82 79.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.594 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.881 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 61.9 m-85 -107.97 121.98 45.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.394 0.616 . . . . 1.0 110.757 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.011 -178.579 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.63 122.64 87.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 6' ' ' PHE . 38.0 Cg_endo -67.74 154.7 72.52 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.024 2.482 . . . . 1.0 113.037 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 37.8 Cg_exo -57.79 144.89 92.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.257 2.638 . . . . 1.0 112.195 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.05 45.4 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.954 -0.566 . . . . 1.0 112.098 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 3' ' ' PRO . 62.9 m-85 -103.21 119.02 38.09 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.848 -178.096 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.671 0.272 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.77 141.13 28.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.235 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.677 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 21.4 Cg_exo -65.64 136.14 44.81 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.846 2.364 . . . . 1.0 112.288 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.3 Cg_exo -57.67 123.97 14.97 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.119 2.546 . . . . 1.0 112.271 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.04 -12.2 68.64 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.181 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.677 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 60.5 m-85 -114.06 111.79 22.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.089 0.471 . . . . 1.0 110.152 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.917 179.228 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.537 0.208 . . . . 1.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.8 mtp85 -91.43 143.46 28.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.694 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.8 Cg_exo -63.11 130.6 29.41 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.678 2.252 . . . . 1.0 112.085 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 16.7 Cg_exo -67.95 111.32 2.39 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.748 2.298 . . . . 1.0 112.925 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.88 -10.08 34.53 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 121.147 -0.549 . . . . 1.0 113.545 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.42 153.43 26.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.864 0.332 . . . . 1.0 111.266 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 1.0 109.801 178.011 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.871 0.367 . . . . 1.0 110.727 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -76.9 149.81 80.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.628 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 34.4 Cg_endo -63.31 129.37 25.23 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.771 2.314 . . . . 1.0 112.49 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.34 144.68 86.62 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.569 2.18 . . . . 1.0 111.204 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.73 -8.59 79.01 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.756 -0.735 . . . . 1.0 111.529 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.628 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -118.7 153.19 34.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.737 -0.211 . . . . 1.0 110.58 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.748 0.308 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 57.7 ttp180 -88.5 122.56 69.38 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.393 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 7.7 Cg_exo -72.1 128.81 14.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.656 2.237 . . . . 1.0 111.701 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 26.7 Cg_exo -64.56 126.29 16.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.984 2.456 . . . . 1.0 112.779 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.39 -11.73 65.13 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.923 -0.656 . . . . 1.0 112.6 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 65.4 m-85 -109.33 110.78 22.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.042 0.448 . . . . 1.0 110.988 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.834 179.048 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.535 0.207 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 84.1 mtt180 -86.45 140.11 33.95 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.599 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 22.5 Cg_exo -66.49 146.13 78.97 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 1.0 111.877 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -59.12 142.87 99.8 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.451 2.101 . . . . 1.0 111.899 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.38 -9.12 41.68 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.632 -0.587 . . . . 1.0 111.632 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.65 111.48 23.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.921 0.391 . . . . 1.0 110.26 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.977 179.329 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.16 -0.311 . . . . 1.0 110.16 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 27.4 mmt180 -81.13 138.61 49.07 Favored Pre-proline 0 N--CA 1.448 -0.539 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.6 146.64 94.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.02 2.48 . . . . 1.0 112.271 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.42 148.0 82.64 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.044 2.496 . . . . 1.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.23 40.87 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.959 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.6 111.99 24.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.746 -177.723 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.961 0.41 . . . . 1.0 111.008 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -83.01 156.61 67.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.304 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 30.7 Cg_exo -61.69 130.14 30.35 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.7 2.267 . . . . 1.0 112.206 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 8.0 Cg_exo -71.23 113.94 3.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 123.5 2.8 . . . . 1.0 112.996 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.18 -11.27 58.43 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.054 -0.521 . . . . 1.0 113.598 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.734 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 62.7 m-85 -92.16 117.5 29.92 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.031 -0.532 . . . . 1.0 111.22 -178.808 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.912 0.387 . . . . 1.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -77.3 146.48 74.4 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.262 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 129.21 19.66 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 1.0 112.143 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.21 154.28 46.47 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.239 2.626 . . . . 1.0 112.488 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.36 -7.8 40.42 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.645 -0.788 . . . . 1.0 113.311 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -92.16 126.43 37.24 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.629 -0.336 . . . . 1.0 110.983 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.358 179.019 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -86.91 121.54 71.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.677 0.275 . . . . 1.0 110.413 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 23.4 Cg_endo -62.58 133.45 42.65 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.993 2.462 . . . . 1.0 112.141 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 15.9 Cg_exo -66.89 128.34 18.63 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.972 2.448 . . . . 1.0 112.508 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.66 1.18 37.06 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.698 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -112.7 151.56 30.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.528 -0.175 . . . . 1.0 110.528 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 m -57.43 131.18 81.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.863 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.49 121.34 3.37 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.936 2.424 . . . . 1.0 111.17 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.149 177.829 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 ptm180 -75.73 136.09 70.91 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.137 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 14.7 Cg_exo -70.25 148.0 60.91 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.601 2.201 . . . . 1.0 111.695 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.53 114.63 2.07 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.816 2.344 . . . . 1.0 112.296 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.97 76.58 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.912 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 53.7 m-85 -105.35 147.29 28.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.157 0.504 . . . . 1.0 110.807 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 m -122.58 148.78 53.99 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.744 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 5.2 Cg_exo -80.58 121.08 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.68 2.254 . . . . 1.0 110.037 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 C--N 1.305 -1.356 0 CA-C-N 115.217 -0.901 . . . . 1.0 110.224 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -89.07 117.04 67.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 121.065 -0.254 . . . . 1.0 110.328 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.909 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 12.8 Cg_exo -70.76 138.13 33.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.743 2.296 . . . . 1.0 111.34 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -58.15 117.98 4.78 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.174 2.583 . . . . 1.0 112.904 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.18 -2.78 54.8 Favored Glycine 0 C--O 1.234 0.154 0 CA-C-N 115.925 -0.579 . . . . 1.0 112.985 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.909 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 64.4 m-85 -111.05 140.93 45.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.076 0.465 . . . . 1.0 111.402 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.2 m -80.46 149.97 69.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.335 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 3.0 Cg_endo -82.52 120.7 3.23 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.087 2.525 . . . . 1.0 111.129 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.608 178.736 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.998 -0.371 . . . . 1.0 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -83.06 145.08 48.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.732 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 36.6 Cg_endo -66.48 131.48 26.42 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.71 2.274 . . . . 1.0 112.411 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.9 138.18 61.68 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.047 2.498 . . . . 1.0 112.846 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.07 -20.59 49.93 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.534 -0.757 . . . . 1.0 112.9 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 59.1 m-85 -91.56 111.83 23.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.2 0.524 . . . . 1.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m -114.36 149.55 42.31 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.779 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -81.36 120.01 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.688 2.259 . . . . 1.0 110.031 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 . . . . . 0 C--N 1.312 -1.054 0 CA-C-N 115.375 -0.83 . . . . 1.0 110.625 -179.077 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -82.74 121.5 77.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.398 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 Cg_endo -65.84 138.94 55.17 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.742 2.295 . . . . 1.0 112.558 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 22.2 Cg_exo -65.54 153.33 78.68 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.526 2.151 . . . . 1.0 112.301 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.73 -2.0 55.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.955 -0.64 . . . . 1.0 112.051 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -114.69 135.27 54.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.551 0.215 . . . . 1.0 110.656 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 m -57.86 156.46 18.76 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.126 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.82 118.6 4.85 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.295 1.997 . . . . 1.0 111.724 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 C--N 1.309 -1.163 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.36 177.069 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.755 0.312 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -89.88 133.8 33.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.54 156.35 52.84 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.85 2.367 . . . . 1.0 112.162 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 140.42 57.39 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.494 2.13 . . . . 1.0 111.964 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.26 -8.96 41.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.744 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -116.48 111.73 20.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.794 -0.446 . . . . 1.0 109.794 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.8 m -62.43 127.86 90.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.93 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.8 Cg_endo -82.79 120.22 3.05 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.333 2.689 . . . . 1.0 111.509 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.646 178.24 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 2' ' ' ARG . 36.0 mmt180 -90.21 136.98 28.05 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.6 0.238 . . . . 1.0 110.601 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 21.6 Cg_exo -67.08 129.5 20.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.692 2.261 . . . . 1.0 112.232 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 143.09 88.88 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.632 2.222 . . . . 1.0 111.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.05 -13.31 45.0 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.817 -0.706 . . . . 1.0 111.512 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -112.6 111.03 21.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m -122.21 138.57 29.17 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.113 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.1 Cg_endo -82.4 121.32 3.4 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.845 2.363 . . . . 1.0 111.105 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 115.186 -0.915 . . . . 1.0 110.01 178.055 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 60.2 mtt180 -74.22 123.95 89.59 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 17.4 Cg_exo -67.66 155.5 69.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.979 2.452 . . . . 1.0 112.135 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.55 141.28 91.01 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.411 2.074 . . . . 1.0 112.495 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.08 43.26 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.629 -0.714 . . . . 1.0 112.42 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -90.46 118.6 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.964 0.411 . . . . 1.0 110.72 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m -85.79 129.9 52.77 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.983 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.7 Cg_endo -82.29 120.78 3.34 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.678 2.252 . . . . 1.0 110.097 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.397 -0.811 . . . . 1.0 110.508 -179.147 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.872 0.368 . . . . 1.0 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.743 ' HD3' ' HG3' ' A' ' 8' ' ' PRO . 88.7 mtt180 -85.31 139.3 36.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.981 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.85 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 6.1 Cg_exo -76.32 129.58 11.29 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.539 2.16 . . . . 1.0 111.516 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 52.5 Cg_exo -54.12 121.65 10.04 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.009 2.472 . . . . 1.0 113.342 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.19 -11.99 48.28 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 1.0 113.036 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.85 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -105.87 126.31 52.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.068 0.461 . . . . 1.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.4 m -83.94 127.03 68.79 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.645 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.743 ' HG3' ' HD3' ' A' ' 2' ' ' ARG . 53.2 Cg_endo -84.97 120.69 2.31 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 122.812 2.341 . . . . 1.0 111.695 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.465 -0.778 . . . . 1.0 110.27 177.564 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.1 pttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.936 0.398 . . . . 1.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 64.3 mtt180 -92.58 136.28 25.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.105 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.711 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 10.8 Cg_exo -71.53 129.49 15.82 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.845 2.363 . . . . 1.0 111.676 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 28.0 Cg_exo -61.06 118.81 5.71 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.86 2.373 . . . . 1.0 112.956 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.91 9.62 86.52 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.928 -0.654 . . . . 1.0 113.729 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.711 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 61.6 m-85 -115.9 136.65 52.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.919 0.36 . . . . 1.0 111.022 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 m -93.75 139.9 22.88 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.045 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.3 Cg_endo -82.28 121.16 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.166 2.577 . . . . 1.0 110.788 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.206 -0.906 . . . . 1.0 110.536 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.8 tttm . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -73.03 126.61 90.34 Favored Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.881 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 3.0 Cg_exo -75.11 143.89 29.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.901 2.4 . . . . 1.0 111.918 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 47.0 Cg_exo -57.4 124.29 15.79 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.806 2.338 . . . . 1.0 112.661 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.82 79.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.594 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.881 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 61.9 m-85 -107.97 121.98 45.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.394 0.616 . . . . 1.0 110.757 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.3 m -122.09 149.69 54.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.011 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.0 OUTLIER -81.89 122.15 3.8 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.061 2.507 . . . . 1.0 110.444 177.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.004 179.322 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.63 122.64 87.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 6' ' ' PHE . 38.0 Cg_endo -67.74 154.7 72.52 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.024 2.482 . . . . 1.0 113.037 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 37.8 Cg_exo -57.79 144.89 92.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.257 2.638 . . . . 1.0 112.195 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.05 45.4 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.954 -0.566 . . . . 1.0 112.098 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 3' ' ' PRO . 62.9 m-85 -103.21 119.02 38.09 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.0 m -64.97 121.15 72.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.848 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 3.0 Cg_endo -83.44 122.2 3.14 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 123.5 2.8 . . . . 1.0 109.92 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--N 1.31 -1.134 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.427 -179.487 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.671 0.272 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.77 141.13 28.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.235 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.677 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 21.4 Cg_exo -65.64 136.14 44.81 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.846 2.364 . . . . 1.0 112.288 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.3 Cg_exo -57.67 123.97 14.97 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.119 2.546 . . . . 1.0 112.271 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.04 -12.2 68.64 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.181 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.677 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 60.5 m-85 -114.06 111.79 22.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.089 0.471 . . . . 1.0 110.152 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m -120.88 153.99 57.46 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.917 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -80.35 119.54 3.82 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.232 1.955 . . . . 1.0 110.601 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 C--O 1.253 1.26 0 CA-C-N 114.812 -1.086 . . . . 1.0 110.884 179.278 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.537 0.208 . . . . 1.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.8 mtp85 -91.43 143.46 28.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.694 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.8 Cg_exo -63.11 130.6 29.41 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.678 2.252 . . . . 1.0 112.085 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 16.7 Cg_exo -67.95 111.32 2.39 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.748 2.298 . . . . 1.0 112.925 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.88 -10.08 34.53 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 121.147 -0.549 . . . . 1.0 113.545 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.42 153.43 26.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.864 0.332 . . . . 1.0 111.266 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.4 m -86.96 136.11 34.5 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 1.0 109.801 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -80.66 119.95 3.8 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 C-N-CA 122.265 1.977 . . . . 1.0 110.488 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 C--N 1.305 -1.343 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.649 179.764 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.871 0.367 . . . . 1.0 110.727 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -76.9 149.81 80.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.628 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 34.4 Cg_endo -63.31 129.37 25.23 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.771 2.314 . . . . 1.0 112.49 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.34 144.68 86.62 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.569 2.18 . . . . 1.0 111.204 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.73 -8.59 79.01 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.756 -0.735 . . . . 1.0 111.529 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.628 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -118.7 153.19 34.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 m -118.72 131.27 24.37 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.737 -0.211 . . . . 1.0 110.58 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.92 121.74 3.7 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.728 2.285 . . . . 1.0 110.375 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.897 -179.523 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.748 0.308 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 57.7 ttp180 -88.5 122.56 69.38 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.393 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 7.7 Cg_exo -72.1 128.81 14.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.656 2.237 . . . . 1.0 111.701 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 26.7 Cg_exo -64.56 126.29 16.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.984 2.456 . . . . 1.0 112.779 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.39 -11.73 65.13 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.923 -0.656 . . . . 1.0 112.6 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 65.4 m-85 -109.33 110.78 22.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.042 0.448 . . . . 1.0 110.988 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -87.13 152.62 53.31 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.834 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.59 121.0 3.26 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 C-N-CA 122.116 1.877 . . . . 1.0 110.386 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--N 1.309 -1.176 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.909 179.815 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.535 0.207 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 84.1 mtt180 -86.45 140.11 33.95 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.599 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 22.5 Cg_exo -66.49 146.13 78.97 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 1.0 111.877 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -59.12 142.87 99.8 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.451 2.101 . . . . 1.0 111.899 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.38 -9.12 41.68 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.632 -0.587 . . . . 1.0 111.632 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.65 111.48 23.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.921 0.391 . . . . 1.0 110.26 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.2 m -78.0 119.56 77.86 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.977 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.49 119.94 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.841 2.36 . . . . 1.0 111.523 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.163 -1.381 . . . . 1.0 111.443 178.793 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.16 -0.311 . . . . 1.0 110.16 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 27.4 mmt180 -81.13 138.61 49.07 Favored Pre-proline 0 N--CA 1.448 -0.539 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.6 146.64 94.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.02 2.48 . . . . 1.0 112.271 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.42 148.0 82.64 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.044 2.496 . . . . 1.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.23 40.87 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.959 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.6 111.99 24.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.499 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.6 m -78.82 123.38 85.26 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.746 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.77 121.94 3.81 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.788 2.326 . . . . 1.0 109.787 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.247 0.946 0 O-C-N 124.434 1.084 . . . . 1.0 110.413 -179.353 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.961 0.41 . . . . 1.0 111.008 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -83.01 156.61 67.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.304 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 30.7 Cg_exo -61.69 130.14 30.35 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.7 2.267 . . . . 1.0 112.206 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 8.0 Cg_exo -71.23 113.94 3.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 123.5 2.8 . . . . 1.0 112.996 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.18 -11.27 58.43 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.054 -0.521 . . . . 1.0 113.598 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.734 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 62.7 m-85 -92.16 117.5 29.92 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.8 m -98.13 108.41 46.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.031 -0.532 . . . . 1.0 111.22 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 2.6 Cg_endo -83.43 120.95 2.92 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 123.197 2.598 . . . . 1.0 111.044 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.254 1.316 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.653 178.214 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.912 0.387 . . . . 1.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -77.3 146.48 74.4 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.262 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 129.21 19.66 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 1.0 112.143 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.21 154.28 46.47 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.239 2.626 . . . . 1.0 112.488 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.36 -7.8 40.42 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.645 -0.788 . . . . 1.0 113.311 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -92.16 126.43 37.24 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.629 -0.336 . . . . 1.0 110.983 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 16.9 m -97.11 136.72 21.37 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.358 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.9 Cg_endo -83.06 119.86 2.89 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.45 2.1 . . . . 1.0 111.655 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 C--O 1.249 1.073 0 O-C-N 124.252 0.97 . . . . 1.0 112.209 177.757 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -86.91 121.54 71.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.677 0.275 . . . . 1.0 110.413 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 23.4 Cg_endo -62.58 133.45 42.65 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.993 2.462 . . . . 1.0 112.141 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 15.9 Cg_exo -66.89 128.34 18.63 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.972 2.448 . . . . 1.0 112.508 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.66 1.18 37.06 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.698 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -112.7 151.56 30.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.528 -0.175 . . . . 1.0 110.528 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.863 -178.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 ptm180 -75.73 136.09 70.91 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.137 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 14.7 Cg_exo -70.25 148.0 60.91 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.601 2.201 . . . . 1.0 111.695 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.53 114.63 2.07 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.816 2.344 . . . . 1.0 112.296 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.97 76.58 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.912 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 53.7 m-85 -105.35 147.29 28.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.157 0.504 . . . . 1.0 110.807 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.744 -179.544 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -89.07 117.04 67.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 121.065 -0.254 . . . . 1.0 110.328 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.909 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 12.8 Cg_exo -70.76 138.13 33.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.743 2.296 . . . . 1.0 111.34 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -58.15 117.98 4.78 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.174 2.583 . . . . 1.0 112.904 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.18 -2.78 54.8 Favored Glycine 0 C--O 1.234 0.154 0 CA-C-N 115.925 -0.579 . . . . 1.0 112.985 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.909 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 64.4 m-85 -111.05 140.93 45.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.076 0.465 . . . . 1.0 111.402 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.335 -178.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.998 -0.371 . . . . 1.0 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -83.06 145.08 48.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.732 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 36.6 Cg_endo -66.48 131.48 26.42 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.71 2.274 . . . . 1.0 112.411 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.9 138.18 61.68 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.047 2.498 . . . . 1.0 112.846 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.07 -20.59 49.93 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.534 -0.757 . . . . 1.0 112.9 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 59.1 m-85 -91.56 111.83 23.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.2 0.524 . . . . 1.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.779 -179.356 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -82.74 121.5 77.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.398 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 Cg_endo -65.84 138.94 55.17 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.742 2.295 . . . . 1.0 112.558 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 22.2 Cg_exo -65.54 153.33 78.68 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.526 2.151 . . . . 1.0 112.301 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.73 -2.0 55.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.955 -0.64 . . . . 1.0 112.051 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -114.69 135.27 54.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.551 0.215 . . . . 1.0 110.656 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.126 178.459 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.755 0.312 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -89.88 133.8 33.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.54 156.35 52.84 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.85 2.367 . . . . 1.0 112.162 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 140.42 57.39 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.494 2.13 . . . . 1.0 111.964 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.26 -8.96 41.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.744 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -116.48 111.73 20.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.794 -0.446 . . . . 1.0 109.794 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.93 -178.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 2' ' ' ARG . 36.0 mmt180 -90.21 136.98 28.05 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.6 0.238 . . . . 1.0 110.601 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 21.6 Cg_exo -67.08 129.5 20.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.692 2.261 . . . . 1.0 112.232 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 143.09 88.88 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.632 2.222 . . . . 1.0 111.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.05 -13.31 45.0 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.817 -0.706 . . . . 1.0 111.512 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -112.6 111.03 21.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.113 -178.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 60.2 mtt180 -74.22 123.95 89.59 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 17.4 Cg_exo -67.66 155.5 69.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.979 2.452 . . . . 1.0 112.135 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.55 141.28 91.01 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.411 2.074 . . . . 1.0 112.495 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.08 43.26 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.629 -0.714 . . . . 1.0 112.42 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -90.46 118.6 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.964 0.411 . . . . 1.0 110.72 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.983 -179.048 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.872 0.368 . . . . 1.0 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 88.7 mtt180 -85.31 139.3 36.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.981 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.85 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 6.1 Cg_exo -76.32 129.58 11.29 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.539 2.16 . . . . 1.0 111.516 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 52.5 Cg_exo -54.12 121.65 10.04 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.009 2.472 . . . . 1.0 113.342 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.19 -11.99 48.28 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 1.0 113.036 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.85 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -105.87 126.31 52.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.068 0.461 . . . . 1.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.645 -179.355 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.1 pttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.936 0.398 . . . . 1.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 64.3 mtt180 -92.58 136.28 25.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.105 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.711 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 10.8 Cg_exo -71.53 129.49 15.82 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.845 2.363 . . . . 1.0 111.676 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 28.0 Cg_exo -61.06 118.81 5.71 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.86 2.373 . . . . 1.0 112.956 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.91 9.62 86.52 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.928 -0.654 . . . . 1.0 113.729 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.711 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 61.6 m-85 -115.9 136.65 52.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.919 0.36 . . . . 1.0 111.022 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.045 -179.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.8 tttm . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -73.03 126.61 90.34 Favored Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.881 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 3.0 Cg_exo -75.11 143.89 29.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.901 2.4 . . . . 1.0 111.918 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 47.0 Cg_exo -57.4 124.29 15.79 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.806 2.338 . . . . 1.0 112.661 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.82 79.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.594 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.881 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 61.9 m-85 -107.97 121.98 45.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.394 0.616 . . . . 1.0 110.757 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.011 -178.579 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.63 122.64 87.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 6' ' ' PHE . 38.0 Cg_endo -67.74 154.7 72.52 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.024 2.482 . . . . 1.0 113.037 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 37.8 Cg_exo -57.79 144.89 92.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.257 2.638 . . . . 1.0 112.195 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.05 45.4 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.954 -0.566 . . . . 1.0 112.098 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 3' ' ' PRO . 62.9 m-85 -103.21 119.02 38.09 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.848 -178.096 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.671 0.272 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.77 141.13 28.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.235 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.677 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 21.4 Cg_exo -65.64 136.14 44.81 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.846 2.364 . . . . 1.0 112.288 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.3 Cg_exo -57.67 123.97 14.97 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.119 2.546 . . . . 1.0 112.271 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.04 -12.2 68.64 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.181 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.677 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 60.5 m-85 -114.06 111.79 22.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.089 0.471 . . . . 1.0 110.152 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.917 179.228 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.537 0.208 . . . . 1.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.8 mtp85 -91.43 143.46 28.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.694 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.8 Cg_exo -63.11 130.6 29.41 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.678 2.252 . . . . 1.0 112.085 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 16.7 Cg_exo -67.95 111.32 2.39 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.748 2.298 . . . . 1.0 112.925 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.88 -10.08 34.53 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 121.147 -0.549 . . . . 1.0 113.545 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.42 153.43 26.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.864 0.332 . . . . 1.0 111.266 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 1.0 109.801 178.011 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.871 0.367 . . . . 1.0 110.727 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -76.9 149.81 80.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.628 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 34.4 Cg_endo -63.31 129.37 25.23 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.771 2.314 . . . . 1.0 112.49 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.34 144.68 86.62 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.569 2.18 . . . . 1.0 111.204 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.73 -8.59 79.01 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.756 -0.735 . . . . 1.0 111.529 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.628 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -118.7 153.19 34.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.737 -0.211 . . . . 1.0 110.58 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.748 0.308 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 57.7 ttp180 -88.5 122.56 69.38 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.393 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 7.7 Cg_exo -72.1 128.81 14.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.656 2.237 . . . . 1.0 111.701 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 26.7 Cg_exo -64.56 126.29 16.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.984 2.456 . . . . 1.0 112.779 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.39 -11.73 65.13 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.923 -0.656 . . . . 1.0 112.6 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 65.4 m-85 -109.33 110.78 22.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.042 0.448 . . . . 1.0 110.988 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.834 179.048 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.535 0.207 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 84.1 mtt180 -86.45 140.11 33.95 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.599 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 22.5 Cg_exo -66.49 146.13 78.97 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 1.0 111.877 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -59.12 142.87 99.8 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.451 2.101 . . . . 1.0 111.899 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.38 -9.12 41.68 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.632 -0.587 . . . . 1.0 111.632 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.65 111.48 23.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.921 0.391 . . . . 1.0 110.26 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.977 179.329 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.16 -0.311 . . . . 1.0 110.16 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 27.4 mmt180 -81.13 138.61 49.07 Favored Pre-proline 0 N--CA 1.448 -0.539 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.6 146.64 94.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.02 2.48 . . . . 1.0 112.271 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.42 148.0 82.64 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.044 2.496 . . . . 1.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.23 40.87 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.959 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.6 111.99 24.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.746 -177.723 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.961 0.41 . . . . 1.0 111.008 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -83.01 156.61 67.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.304 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 30.7 Cg_exo -61.69 130.14 30.35 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.7 2.267 . . . . 1.0 112.206 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 8.0 Cg_exo -71.23 113.94 3.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 123.5 2.8 . . . . 1.0 112.996 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.18 -11.27 58.43 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.054 -0.521 . . . . 1.0 113.598 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.734 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 62.7 m-85 -92.16 117.5 29.92 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.031 -0.532 . . . . 1.0 111.22 -178.808 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.912 0.387 . . . . 1.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -77.3 146.48 74.4 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.262 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 129.21 19.66 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 1.0 112.143 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.21 154.28 46.47 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.239 2.626 . . . . 1.0 112.488 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.36 -7.8 40.42 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.645 -0.788 . . . . 1.0 113.311 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -92.16 126.43 37.24 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.629 -0.336 . . . . 1.0 110.983 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.358 179.019 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -86.91 121.54 71.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.677 0.275 . . . . 1.0 110.413 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 23.4 Cg_endo -62.58 133.45 42.65 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.993 2.462 . . . . 1.0 112.141 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 15.9 Cg_exo -66.89 128.34 18.63 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.972 2.448 . . . . 1.0 112.508 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.66 1.18 37.06 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.698 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -112.7 151.56 30.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.528 -0.175 . . . . 1.0 110.528 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 m -57.43 131.18 81.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.863 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.49 121.34 3.37 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.936 2.424 . . . . 1.0 111.17 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.149 177.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 ptm180 -75.73 136.09 70.91 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.137 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 14.7 Cg_exo -70.25 148.0 60.91 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.601 2.201 . . . . 1.0 111.695 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.53 114.63 2.07 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.816 2.344 . . . . 1.0 112.296 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.97 76.58 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.912 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 53.7 m-85 -105.35 147.29 28.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.157 0.504 . . . . 1.0 110.807 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 m -122.58 148.78 53.99 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.744 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 5.2 Cg_exo -80.58 121.08 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.68 2.254 . . . . 1.0 110.037 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 C--N 1.305 -1.356 0 CA-C-N 115.217 -0.901 . . . . 1.0 110.224 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -89.07 117.04 67.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 121.065 -0.254 . . . . 1.0 110.328 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.909 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 12.8 Cg_exo -70.76 138.13 33.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.743 2.296 . . . . 1.0 111.34 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -58.15 117.98 4.78 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.174 2.583 . . . . 1.0 112.904 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.18 -2.78 54.8 Favored Glycine 0 C--O 1.234 0.154 0 CA-C-N 115.925 -0.579 . . . . 1.0 112.985 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.909 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 64.4 m-85 -111.05 140.93 45.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.076 0.465 . . . . 1.0 111.402 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.2 m -80.46 149.97 69.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.335 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 3.0 Cg_endo -82.52 120.7 3.23 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.087 2.525 . . . . 1.0 111.129 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.608 178.736 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.998 -0.371 . . . . 1.0 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -83.06 145.08 48.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.732 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 36.6 Cg_endo -66.48 131.48 26.42 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.71 2.274 . . . . 1.0 112.411 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.9 138.18 61.68 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.047 2.498 . . . . 1.0 112.846 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.07 -20.59 49.93 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.534 -0.757 . . . . 1.0 112.9 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 59.1 m-85 -91.56 111.83 23.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.2 0.524 . . . . 1.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m -114.36 149.55 42.31 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.779 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -81.36 120.01 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.688 2.259 . . . . 1.0 110.031 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 . . . . . 0 C--N 1.312 -1.054 0 CA-C-N 115.375 -0.83 . . . . 1.0 110.625 -179.077 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -82.74 121.5 77.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.398 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 Cg_endo -65.84 138.94 55.17 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.742 2.295 . . . . 1.0 112.558 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 22.2 Cg_exo -65.54 153.33 78.68 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.526 2.151 . . . . 1.0 112.301 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.73 -2.0 55.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.955 -0.64 . . . . 1.0 112.051 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -114.69 135.27 54.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.551 0.215 . . . . 1.0 110.656 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 m -57.86 156.46 18.76 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.126 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.82 118.6 4.85 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.295 1.997 . . . . 1.0 111.724 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 C--N 1.309 -1.163 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.36 177.069 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.755 0.312 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -89.88 133.8 33.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.54 156.35 52.84 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.85 2.367 . . . . 1.0 112.162 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 140.42 57.39 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.494 2.13 . . . . 1.0 111.964 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.26 -8.96 41.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.744 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -116.48 111.73 20.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.794 -0.446 . . . . 1.0 109.794 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.8 m -62.43 127.86 90.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.93 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.8 Cg_endo -82.79 120.22 3.05 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.333 2.689 . . . . 1.0 111.509 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.646 178.24 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 2' ' ' ARG . 36.0 mmt180 -90.21 136.98 28.05 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.6 0.238 . . . . 1.0 110.601 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 21.6 Cg_exo -67.08 129.5 20.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.692 2.261 . . . . 1.0 112.232 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.23 143.09 88.88 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.632 2.222 . . . . 1.0 111.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.05 -13.31 45.0 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.817 -0.706 . . . . 1.0 111.512 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -112.6 111.03 21.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m -122.21 138.57 29.17 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.113 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.1 Cg_endo -82.4 121.32 3.4 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.845 2.363 . . . . 1.0 111.105 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 115.186 -0.915 . . . . 1.0 110.01 178.055 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 60.2 mtt180 -74.22 123.95 89.59 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 17.4 Cg_exo -67.66 155.5 69.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.979 2.452 . . . . 1.0 112.135 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.55 141.28 91.01 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.411 2.074 . . . . 1.0 112.495 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.08 43.26 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.629 -0.714 . . . . 1.0 112.42 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -90.46 118.6 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.964 0.411 . . . . 1.0 110.72 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m -85.79 129.9 52.77 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.983 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.7 Cg_endo -82.29 120.78 3.34 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.678 2.252 . . . . 1.0 110.097 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.397 -0.811 . . . . 1.0 110.508 -179.147 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.872 0.368 . . . . 1.0 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.743 ' HD3' ' HG3' ' A' ' 8' ' ' PRO . 88.7 mtt180 -85.31 139.3 36.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.981 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.85 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 6.1 Cg_exo -76.32 129.58 11.29 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.539 2.16 . . . . 1.0 111.516 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 52.5 Cg_exo -54.12 121.65 10.04 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.009 2.472 . . . . 1.0 113.342 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.19 -11.99 48.28 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 1.0 113.036 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.85 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -105.87 126.31 52.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.068 0.461 . . . . 1.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.4 m -83.94 127.03 68.79 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.645 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.743 ' HG3' ' HD3' ' A' ' 2' ' ' ARG . 53.2 Cg_endo -84.97 120.69 2.31 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 122.812 2.341 . . . . 1.0 111.695 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.465 -0.778 . . . . 1.0 110.27 177.564 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.1 pttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.936 0.398 . . . . 1.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 64.3 mtt180 -92.58 136.28 25.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.105 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.711 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 10.8 Cg_exo -71.53 129.49 15.82 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.845 2.363 . . . . 1.0 111.676 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 28.0 Cg_exo -61.06 118.81 5.71 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.86 2.373 . . . . 1.0 112.956 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.91 9.62 86.52 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.928 -0.654 . . . . 1.0 113.729 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.711 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 61.6 m-85 -115.9 136.65 52.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.919 0.36 . . . . 1.0 111.022 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 m -93.75 139.9 22.88 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.045 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.3 Cg_endo -82.28 121.16 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.166 2.577 . . . . 1.0 110.788 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.206 -0.906 . . . . 1.0 110.536 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.8 tttm . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -73.03 126.61 90.34 Favored Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.881 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 3.0 Cg_exo -75.11 143.89 29.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.901 2.4 . . . . 1.0 111.918 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 47.0 Cg_exo -57.4 124.29 15.79 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.806 2.338 . . . . 1.0 112.661 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.82 79.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.594 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.881 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 61.9 m-85 -107.97 121.98 45.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.394 0.616 . . . . 1.0 110.757 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.3 m -122.09 149.69 54.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.011 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.0 OUTLIER -81.89 122.15 3.8 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.061 2.507 . . . . 1.0 110.444 177.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.446 -0.797 . . . . 1.0 111.004 179.322 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.63 122.64 87.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 6' ' ' PHE . 38.0 Cg_endo -67.74 154.7 72.52 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.024 2.482 . . . . 1.0 113.037 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 37.8 Cg_exo -57.79 144.89 92.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.257 2.638 . . . . 1.0 112.195 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.05 45.4 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.954 -0.566 . . . . 1.0 112.098 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 3' ' ' PRO . 62.9 m-85 -103.21 119.02 38.09 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.0 m -64.97 121.15 72.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.848 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 3.0 Cg_endo -83.44 122.2 3.14 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 123.5 2.8 . . . . 1.0 109.92 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--N 1.31 -1.134 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.427 -179.487 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.671 0.272 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.77 141.13 28.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.235 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.677 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 21.4 Cg_exo -65.64 136.14 44.81 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.846 2.364 . . . . 1.0 112.288 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.3 Cg_exo -57.67 123.97 14.97 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.119 2.546 . . . . 1.0 112.271 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.04 -12.2 68.64 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.181 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.677 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 60.5 m-85 -114.06 111.79 22.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.089 0.471 . . . . 1.0 110.152 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m -120.88 153.99 57.46 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.917 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -80.35 119.54 3.82 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.232 1.955 . . . . 1.0 110.601 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 C--O 1.253 1.26 0 CA-C-N 114.812 -1.086 . . . . 1.0 110.884 179.278 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.537 0.208 . . . . 1.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.8 mtp85 -91.43 143.46 28.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.694 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.8 Cg_exo -63.11 130.6 29.41 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.678 2.252 . . . . 1.0 112.085 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 16.7 Cg_exo -67.95 111.32 2.39 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.748 2.298 . . . . 1.0 112.925 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.88 -10.08 34.53 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 121.147 -0.549 . . . . 1.0 113.545 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.42 153.43 26.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.864 0.332 . . . . 1.0 111.266 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.4 m -86.96 136.11 34.5 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 1.0 109.801 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -80.66 119.95 3.8 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 C-N-CA 122.265 1.977 . . . . 1.0 110.488 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 C--N 1.305 -1.343 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.649 179.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.871 0.367 . . . . 1.0 110.727 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -76.9 149.81 80.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.628 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 34.4 Cg_endo -63.31 129.37 25.23 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.771 2.314 . . . . 1.0 112.49 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.34 144.68 86.62 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.569 2.18 . . . . 1.0 111.204 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.73 -8.59 79.01 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.756 -0.735 . . . . 1.0 111.529 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.628 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 63.8 m-85 -118.7 153.19 34.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 m -118.72 131.27 24.37 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.737 -0.211 . . . . 1.0 110.58 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.92 121.74 3.7 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.728 2.285 . . . . 1.0 110.375 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.897 -179.523 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.748 0.308 . . . . 1.0 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 57.7 ttp180 -88.5 122.56 69.38 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.393 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HB2' ' HD1' ' A' ' 6' ' ' PHE . 7.7 Cg_exo -72.1 128.81 14.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.656 2.237 . . . . 1.0 111.701 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 26.7 Cg_exo -64.56 126.29 16.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.984 2.456 . . . . 1.0 112.779 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.39 -11.73 65.13 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.923 -0.656 . . . . 1.0 112.6 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' HD1' ' HB2' ' A' ' 3' ' ' PRO . 65.4 m-85 -109.33 110.78 22.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.042 0.448 . . . . 1.0 110.988 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -87.13 152.62 53.31 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.834 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.59 121.0 3.26 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 C-N-CA 122.116 1.877 . . . . 1.0 110.386 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--N 1.309 -1.176 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.909 179.815 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.535 0.207 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 84.1 mtt180 -86.45 140.11 33.95 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.599 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 22.5 Cg_exo -66.49 146.13 78.97 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 1.0 111.877 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 32.0 Cg_exo -59.12 142.87 99.8 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.451 2.101 . . . . 1.0 111.899 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.38 -9.12 41.68 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.632 -0.587 . . . . 1.0 111.632 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.65 111.48 23.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.921 0.391 . . . . 1.0 110.26 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.2 m -78.0 119.56 77.86 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.977 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.49 119.94 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.841 2.36 . . . . 1.0 111.523 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.163 -1.381 . . . . 1.0 111.443 178.793 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.16 -0.311 . . . . 1.0 110.16 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' ARG . 27.4 mmt180 -81.13 138.61 49.07 Favored Pre-proline 0 N--CA 1.448 -0.539 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.6 146.64 94.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.02 2.48 . . . . 1.0 112.271 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.42 148.0 82.64 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.044 2.496 . . . . 1.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.23 40.87 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.959 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.6 111.99 24.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.499 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.6 m -78.82 123.38 85.26 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.746 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.2 Cg_endo -81.77 121.94 3.81 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.788 2.326 . . . . 1.0 109.787 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.247 0.946 0 O-C-N 124.434 1.084 . . . . 1.0 110.413 -179.353 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.961 0.41 . . . . 1.0 111.008 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -83.01 156.61 67.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.304 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 30.7 Cg_exo -61.69 130.14 30.35 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.7 2.267 . . . . 1.0 112.206 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 8.0 Cg_exo -71.23 113.94 3.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 123.5 2.8 . . . . 1.0 112.996 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.18 -11.27 58.43 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.054 -0.521 . . . . 1.0 113.598 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.734 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 62.7 m-85 -92.16 117.5 29.92 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.8 m -98.13 108.41 46.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.031 -0.532 . . . . 1.0 111.22 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 2.6 Cg_endo -83.43 120.95 2.92 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 123.197 2.598 . . . . 1.0 111.044 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.254 1.316 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.653 178.214 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.912 0.387 . . . . 1.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -77.3 146.48 74.4 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.262 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 129.21 19.66 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 1.0 112.143 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.21 154.28 46.47 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.239 2.626 . . . . 1.0 112.488 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.36 -7.8 40.42 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.645 -0.788 . . . . 1.0 113.311 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -92.16 126.43 37.24 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.629 -0.336 . . . . 1.0 110.983 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 16.9 m -97.11 136.72 21.37 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.358 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' SER . 1.9 Cg_endo -83.06 119.86 2.89 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.45 2.1 . . . . 1.0 111.655 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 C--O 1.249 1.073 0 O-C-N 124.252 0.97 . . . . 1.0 112.209 177.757 . . . . . . . . 0 0 . 1 stop_ save_